CeriBell (CBLL) vs Integra LifeSciences (IART)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
CeriBell (CBLL) has outperformed Integra LifeSciences (IART) over the past year, gaining 89.1% versus a loss of 9.5%. Integra LifeSciences is the larger company by market cap ($1.04 billion vs $888.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBLL | IART |
|---|---|---|
| Share price | $23.15 | $13.41 |
| Market cap | $888.45M | $1.04B |
| 1-day change | -1.41% | +3.15% |
| YTD return | +5.56% | +7.97% |
| 1-year return | +89.13% | -9.45% |
| 5-year return | — | -80.19% |
| Forward P/E | — | 5.16 |
| EPS (TTM) | $-1.76 | $-0.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.63 | $20.49 |
| 52-week low | $10.85 | $8.70 |
| Distance from 52-week high | -9.67% | -34.55% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +23.41% | +37.06% |
| Average volume | 370.29K | 916.55K |
| Shares outstanding | 38.38M | 77.77M |
| Employees | 327 | 4,427 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CBLL has outperformed IART by 98.6 percentage points over the past year.
About CeriBell
CBLL stock →CeriBell, Inc. operates as a medical technology company in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 327 employees
About Integra LifeSciences
IART stock →Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.
Health Care · Medical/Dental Instruments · 4,427 employees
CBLL vs IART FAQ
Which is bigger, CeriBell or Integra LifeSciences?
Integra LifeSciences (IART) is larger, with a market capitalization of $1.04B compared with $888.45M for CeriBell (CBLL).
Which stock has performed better over the past year, CBLL or IART?
CBLL returned +89.13% over the past 12 months, compared with -9.45% for IART (price return, excluding dividends). Past performance does not predict future results.
Are CeriBell and Integra LifeSciences in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for CeriBell and Medical/Dental Instruments for Integra LifeSciences.